ARTICLE | Company News
Futura, Stada Arzneimittel deal
January 13, 2017 7:49 PM UTC
Futura granted Stada’s Thornton & Ross Ltd. subsidiary rights to commercialize pain candidate TPR100 in the U.K. Thornton & Ross will submit a regulatory application next half. Futura will receive an ...